1. PAL S. EVALUATION OF CYSTATIN C AS AN EARLY MARKER OF RENAL IMPAIRMENT IN DIABETIC AND HYPERLIPIDAEMIC PATIENTS. World Res J Med Sci [Internet].Bioinfo Publications : 1(1): 13-17.